MMP14 and sarcoma: Lastly, the development of a good manufacturingpractice compliant production method will be required for human administrationand evaluation in early phase clinical trials to assess the feasibility,safety profile, and optimal dosing of [89Zr]Zr-DFO-anti-MT1-MMP-IRDye800CWfor pre-operative PET imaging and FGS in patients with bone and softtissue sarcomas.